RushNet, Inc. (RSHN)
OTC
Healthcare
Medical - Diagnostics & Research
$0.00
▲ +0.00%
Market Cap
$857,642
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
-0.54
52-Wk Range
0.00005-0.0001
CEO
Michael A. Cunha
Country
US
Currency
USD
RushNet, Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Jacksonville, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $857,642. On trailing twelve-month figures it carries a trailing P/E of -1.00, a net margin of -34.0%. Its beta of -0.54 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-1.00
Price / Sales
0.48
Price / Book
-4.48
EV / EBITDA
-9.20
Gross margin
61.8%
Operating margin
-38.3%
Net margin
-34.0%
Return on equity
—
Debt / equity
-25.20
Current ratio
0.29
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
17
IPO date
1998-10-20
Headquarters
Jacksonville, FL, US
About RushNet, Inc.
RushNet, Inc. provides laboratory diagnostic testing services. It offers high-complexity urine drug testing, behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease services. The company is based in Jacksonville, Florida.
Comparable companies
RushNet, Inc. is most often compared with the following Healthcare names:
More research on RSHN
Open full interactive analysis & DCF →